Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bitcoin Bancorp Announces FINRA Completion of Corporate Name Change to Bitcoin Bancorp and New Trading Symbol “BCBC”
-
Sono-Tek Reports Fiscal Second Quarter Financial Results and Record First Half 2026 Revenue
-
Verde AgriTech Board Approves Accelerated Plan for District Scale Rare Earths Discovery
-
American Tungsten Announces $10 Million Non-Brokered LIFE Private Placement
-
ValOre & VRIFY Expand Partnership in Brazil; Corporate Update
-
Municipality Finance will redeem early notes issued under its MTN programme
-
BlossomHill Therapeutics Announces Upcoming Poster Presentation on Phase 1/2 SOLARA Trial of BH-30643, a First-in-class, Macrocyclic OMNI-EGFR™ Inhibitor, at the AACR-NCI-EORTC International Confere
-
Avalon Announces Brokered LIFE Financing of up to C$21 Million to Advance its Rare Earth and Lithium Projects in Canada
-
Abcourt Reports First Quarter Operations Update for the Sleeping Giant Mine Development
-
Pi Named a TIME Best Invention of 2025 in Logistics
-
I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
-
BPGbio Welcomes Sheikh Dr. Khalid Bin Jabor Al Thani as Executive in Residence
-
REKOR SYSTEMS EXPECTS Q3 2025 RECORD REVENUE, A SIGNIFICANT IMPROVEMENT IN ADJUSTED EBITDA AND GROSS MARGIN
-
OTC Markets Group Welcomes Aspira Women's Health Inc. to OTCQX
-
Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplan
-
Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation
-
TradePending Joins the Mazda Digital Certified Program
-
Nusano and Ariceum Therapeutics Announce Multi-Isotope Supply Agreement
-
Inception Growth Acquisition Limited Announces Extension of Business Combination Period
-
AlphaTON Capital CEO Brittany Kaiser and SkyBridge Capital Founder Anthony Scaramucci Join Schwab Network’s Trading 360 to Discuss Crypto Innovation and Cancer Research Funding
-
SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics
-
Iantrek Announces Commercial Launch of AlloFlo™ Uveo, the Only Surgical Treatment Targeting the Uveoscleral Pathway in Glaucoma
-
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
-
Assembly Biosciences Announces Upcoming Investor Conference Participation
-
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025
-
Aduro Clean Technologies to Participate in the 51st Annual New Orleans Investment Conference
-
The Future of Marketing To Take Center Stage at OAAA’s 2026 OOH Media Conference
-
Bitfarms Announces the Retirement of Jeff Lucas, Chief Financial Officer, and the Appointment of Jonathan Mir as Successor
-
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
-
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes
-
REKOR SYSTEMS EXPECTS Q3 2025 RECORD REVENUE, A SIGNIFICANT IMPROVEMENT IN ADJUSTED EBITDA AND GROSS MARGIN
-
Talen Energy to Report Third Quarter 2025 Financial Results on November 5, 2025
-
Frontier Medicines Announces Third Precision Oncology Development Candidate
-
OTC Markets Group Welcomes Aspira Women's Health Inc. to OTCQX
-
ESGold Reports Positive Results from Colombian Tailings
-
CECO Environmental to Release Third Quarter Earnings and Host Conference Call on October 28
-
Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025
-
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
-
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
-
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
-
Meet The Winners of the 2025 'MADE in NJ' Manufacturing Day Awards
-
YieldMax® ETFs Announces Weekly Distributions on ULTY, LFGY, YMAX, YMAG, SLTY, and Others
-
Castellum, Inc.’s Subsidiary Specialty Systems, Inc. Adds IT Services for GSA MAS Contract
-
Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity
-
K92 Mining Announces 2025 Third Quarter Financial Results Conference Call Details
-
Cespira Signs Agreement to Supply Components for a Customer Truck Trial
-
Clearway Energy, Inc. to Report Third Quarter 2025 Financial Results on November 4, 2025
-
Nova Minerals Engaged Ahead of High-Level Critical Minerals Talks with U.S. President Donald Trump
-
Record Number of Participants Deployed Kraken Robotics’ Synthetic Aperture Sonar at REPMUS 2025
-
Fixing of coupon rates - Nykredit Realkredit A/S
